Market revenue in 2023 | USD 854.5 million |
Market revenue in 2030 | USD 2,536.1 million |
Growth rate | 16.8% (CAGR from 2023 to 2030) |
Largest segment | Bioreactors/fermenters |
Fastest growing segment | Cell Culture Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags & Containers |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Corning Inc, Sartorius AG, Eppendorf, Danaher Corp, Boehringer Ingelheim, Getinge AB Class B, Lonza Group Ltd, Avantor Inc, Repligen Corp, Entegris Inc, PBS Biotech, Meissner, Kuhner Shaker |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to upstream bioprocessing market will help companies and investors design strategic landscapes.
Bioreactors/fermenters was the largest segment with a revenue share of 31.05% in 2023. Horizon Databook has segmented the India upstream bioprocessing market based on bioreactors/fermenters, cell culture products, filters, bioreactors accessories, bags & containers covering the revenue growth of each sub-segment from 2018 to 2030.
The robust growth of India's bio economy, recording a double-digit year-on-year growth rate for the past 9 years, is expected to drive the country to become one of the top five global bio-manufacturing hubs by 2025. From a bio economy valuation of approximately USD 10 billion in 2014, it reached USD 80 billion in 2023, marking an eightfold increase in 8/9 years.
The remarkable expansion of biotech startups, growing from 52 in 2014 to over 6,300 in 2023, further accentuates India's emergence as a significant force in the upstream bioprocessing market, highlighting a continued upward trajectory of the bio economy with a projected USD 300 billion by 2030.
For instance, in April 2023, at the Biopharma Excellence Awards (BEA) India Edition 2023, India awarded Avantor, Inc., specializing in life sciences and advanced technologies, with the Best Bioprocessing Supplier Award for Gene and Cell Therapy.
Horizon Databook provides a detailed overview of country-level data and insights on the India upstream bioprocessing market , including forecasts for subscribers. This country databook contains high-level insights into India upstream bioprocessing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account